|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5640 EUR | -7.84% |
|
-18.61% | -63.28% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AB SCIENCE | Specialty & Advanced Pharmaceuticals | -7.84% | -18.61% | -63.28% | -54.59% | -96.43% | 56.03M |  | | |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
